Photochemical mRNA Delivery via Light-Activated Endosomal Disruption

Solution Overview

Problem

Current methods for delivering mRNA into cells in vivo face challenges such as toxicity, lack of control over delivery timing and location, and inefficiency compared to traditional carriers like lipofectamine.

Innovation Solution

A photochemical internalization (PCI) method using a photosensitizing agent, such as sulphonated meso-tetraphenyl chlorin, and controlled light irradiation to facilitate the release of mRNA into the cytosol, avoiding the need for transfection agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional carriers like lipofectamine are used for mRNA delivery, then delivery efficiency is improved, but toxic reactions occur limiting clinical applications

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and eliminates the carrier component from the mRNA delivery system. By using photochemical internalization, mRNA can be delivered without requiring cationic lipid carriers like lipofectamine, thereby removing the source of toxic reactions while maintaining delivery capability through light-activated endosomal membrane disruption

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces a photosensitizing agent as an intermediary substance that enables controlled mRNA release. The photosensitizer localizes in endocytic membranes and, upon light activation, generates reactive oxygen species that selectively disrupt endosomal membranes to release mRNA into the cytosol without requiring toxic carriers

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If carriers are used for mRNA delivery, then mRNA can be delivered into cells, but control over delivery timing and location is lost

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The invention introduces dynamic control to the mRNA delivery process through light activation. The photosensitizing agent remains inactive until illuminated, allowing the delivery process to be dynamically controlled in time and space. Light can be applied at specific locations and times to trigger precise mRNA release where and when needed

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The photosensitizing agent is pre-loaded into endocytic compartments along with mRNA before light activation. This preliminary positioning ensures that when light is applied, the mRNA is immediately released at the correct location without requiring additional targeting steps, achieving both efficiency and spatial control

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If photochemical internalization is used for mRNA delivery, then controlled and timed release is achieved, but the method complexity increases

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The photosensitizing agent self-localizes to endocytic membranes through its inherent amphiphilic properties without requiring complex targeting moieties or external guidance systems. The agent autonomously positions itself where needed, and light activation automatically triggers the release mechanism, eliminating the need for complex control systems

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention replaces complex mechanical or chemical control systems with a simple optical trigger. Instead of using complex pumps, valves, or chemical triggers to control mRNA release, a straightforward light irradiation step activates the photosensitizer to generate reactive oxygen species that disrupt membranes and release mRNA, significantly simplifying the control mechanism

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method achieves superior in vivo delivery of mRNA to target cells, with enhanced protein expression compared to traditional methods, and allows for controlled and timed release of mRNA, minimizing side effects.

Implementation Method 1

Photochemical internalization (PCI) is a strategy based on light-induced rupture of endocytic membranes, triggered by the use of a photosensitising compound that localizes in these membranes. Upon illumination, the photosensitising compound initiates an oxidative process by creating reactive oxygen species (ROS) that destroys the membrane.

Methodology Applied
Scientific EffectPhotochemical internalisation: Photo-oxidation

Data Source

PatentUS12263182B2Method of introducing an mRNA molecule into a cell
Publication Date: 2025.04.01
  • US12263182B2 patent drawing
  • US12263182B2 patent drawing
  • US12263182B2 patent drawing

AI summary

The present invention concerns an in vivo method for introducing an mRNA molecule (which is not associated with a carrier) into the cytosol of a cell(s) in a subject, by the use of photochemical internalization, wherein the photosensitising agent is a sulphonated meso-tetraphenyl chlorin, sulfonated tetraphenylporphine or a di- or tetrasulfonated aluminium phthalocyanine used in an amount of 0.0001 to 1 μg. The method may be used to express a polypeptide in the subject. The invention is also directed to pharmaceutical compositions containing the photosensitising agents and the mRNA and uses of the molecules in therapy, e.g. to treat or prevent cancer or an infection.